Not about to shout the bar, but another box ticked on the road to a killer product, and a hefty reward for shareholders.
- Forums
- ASX - By Stock
- NEU
- Ann: Trofinetide successful in Phase 2 trial in Fragile X
Ann: Trofinetide successful in Phase 2 trial in Fragile X, page-4
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.16 |
Change
0.030(0.23%) |
Mkt cap ! $1.683B |
Open | High | Low | Value | Volume |
$13.22 | $13.32 | $13.01 | $2.145M | 163.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 327 | $13.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.17 | 937 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 143 | 13.200 |
6 | 592 | 13.190 |
10 | 1268 | 13.180 |
6 | 611 | 13.170 |
5 | 637 | 13.160 |
Price($) | Vol. | No. |
---|---|---|
13.220 | 686 | 8 |
13.230 | 898 | 6 |
13.240 | 897 | 6 |
13.250 | 804 | 5 |
13.260 | 1766 | 6 |
Last trade - 13.15pm 21/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online